KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pacira BioSciences (PCRX) over the last 17 years, with Q3 2025 value amounting to 0.56.

  • Pacira BioSciences' Equity Ratio rose 1377.21% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year increase of 1377.21%. This contributed to the annual value of 0.5 for FY2024, which is 934.64% down from last year.
  • Pacira BioSciences' Equity Ratio amounted to 0.56 in Q3 2025, which was up 1377.21% from 0.49 recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Equity Ratio ranged from a high of 0.56 in Q1 2024 and a low of 0.35 during Q4 2021
  • For the 5-year period, Pacira BioSciences' Equity Ratio averaged around 0.49, with its median value being 0.5 (2023).
  • In the last 5 years, Pacira BioSciences' Equity Ratio tumbled by 2761.56% in 2021 and then skyrocketed by 3439.01% in 2023.
  • Quarter analysis of 5 years shows Pacira BioSciences' Equity Ratio stood at 0.35 in 2021, then surged by 30.98% to 0.46 in 2022, then rose by 19.89% to 0.55 in 2023, then dropped by 9.35% to 0.5 in 2024, then grew by 11.86% to 0.56 in 2025.
  • Its Equity Ratio was 0.56 in Q3 2025, compared to 0.49 in Q2 2025 and 0.5 in Q1 2025.